NHS offers 'new hope' for children with severe epilepsy

Hundreds of children with severe epilepsy will be able to benefit from a groundbreaking new treatment on the NHS that could significantly reduce their seizures.

© Pexels/Pixabay

© Pexels/Pixabay

The drug, fenfluramine, will be funded for NHS patients in England from 20 February after NICE recommended it for seizures associated with Lennox–Gastaut syndrome (LGS) in people aged two years and over. It is the first non-cannabis-based treatment approved for this form of epilepsy.

LGS is a rare, lifelong, and treatment-resistant form of epilepsy that causes frequent, unpredictable, and debilitating seizures. In severe cases, children may experience multiple seizures throughout the day, significantly impacting their quality of life. These seizures often lead to cognitive issues, difficulties with mobility, and an increased risk of injury due to sudden loss of muscle control.

Fenfluramine is an oral liquid medicine taken daily, with the dose tailored to each patient based on their weight. It works by increasing the levels of serotonin in the brain, which helps to reduce seizure activity.

Professor Stephen Powis, national medical director for NHS England, said: ‘To have a proven, evidence-based new medicine that can be taken at home to help control and reduce their child's seizures, and for example lower the risk of them experiencing injuries and needing to go to hospital, is fantastic news for hundreds of families.

‘Fenfluramine will offer a vital alternative for those who can't tolerate existing cannabis-based treatment and the fast-tracking of this treatment to be available from today is another example of the NHS' commitment to ensuring access to the best therapies that deliver real benefits to patients as well as value for the taxpayer.'

UCLH app helps clinicians manage patients' menopause symptoms

UCLH app helps clinicians manage patients' menopause symptoms

By Liz Wells 31 July 2025

Doctors at University College London Hospitals (UCLH) and University College London (UCL) have developed an app to help clinicians manage menopause symptoms.

APP

AI-powered physiotherapy halves NHS back pain waiting list

By Liz Wells 31 July 2025

A new AI-powered physiotherapy clinic, which provides same-day appointments for back pain via an app, has more than halved waiting lists for back pain in its...

Union seeks judicial review over Leng Review

By Liz Wells 30 July 2025

United Medical Associate Professionals (UMAPs) has sent pre-action letters to health secretary Wes Streeting and NHS England notifying them of an intended ju...


Popular articles by Liz Wells